School of Biological Sciences, University of Wollongong, Wollongong, NSW, 2522, Australia.
Curr Drug Targets. 2012 Mar;13(3):297-307. doi: 10.2174/138945012799424589.
Streptococcus pyogenes is a major human pathogen responsible for numerous diseases ranging from uncomplicated skin and throat infections to severe, life threatening invasive disease such as necrotising fasciitis and streptococcal toxic shock syndrome. These severe invasive infections progress rapidly and produce high rates of morbidity and mortality despite the implementation of aggressive treatment plans. The activation of plasminogen and the acquisition of plasmin activity at the bacterial cell surface is critical for the invasive pathogenesis of this organism. To facilitate this process, S. pyogenes secrete streptokinase, a potent plasminogen activating protein. Here, we describe the role of streptokinase in invasive pathogenesis and discuss some potentially useful strategies for disruption of streptokinase mediated plasminogen activation which could be employed to treat severe invasive S. pyogenes infections.
化脓链球菌是一种主要的人类病原体,可导致多种疾病,从简单的皮肤和喉咙感染到严重的、危及生命的侵袭性疾病,如坏死性筋膜炎和链球菌中毒性休克综合征。尽管实施了积极的治疗计划,但这些严重的侵袭性感染进展迅速,发病率和死亡率很高。纤溶酶原在细菌细胞表面的激活和获得纤溶酶活性对于该生物体的侵袭发病机制至关重要。为了促进这一过程,化脓链球菌分泌链激酶,一种有效的纤溶酶原激活蛋白。在这里,我们描述了链激酶在侵袭发病机制中的作用,并讨论了一些可能有用的策略来破坏链激酶介导的纤溶酶原激活,这可以用于治疗严重的侵袭性化脓链球菌感染。